Evidence map›Paper›PMID 32280221›Full record

ArticleInternational journal of nanomedicine2020

Mitochondria-Modulating Porous Se@SiO

Muyun Wang, Kun Wang, Guoying Deng, Xijian Liu, Xiaodong Wu, Haiyang Hu, Yanbei Zhang, Wei Gao, Qiang Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Porous Se@SiOMolecular medicine (Cambridge, Mass.) · 2024
    Article
  8. Article
  9. Review
  10. Combining Porous Se@SiOInternational journal of nanomedicine · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Current views in chronic obstructive pulmonary disease pathogenesis and management.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  16. Review
  17. Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.International journal of nanomedicine · 2021
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Muyun Wang *Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, People's Republic of China.
Kun Wang *Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, People's Republic of China.
Guoying Deng *Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, People's Republic of China.ORCID 0000-0002-1693-8453
Xijian LiuCollege of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, People's Republic of China.ORCID 0000-0001-5856-9142
Xiaodong WuDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, People's Republic of China.
Haiyang HuDepartment of Cardiothoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, People's Republic of China.
Yanbei ZhangDepartment of Geriatric Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Anhui 230022, People's Republic of China.
Wei GaoDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, People's Republic of China.
Qiang LiDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, People's Republic of China.
Shanghai East Hospital · CNShanghai Jiao Tong University · CNAnhui Medical University · CNShanghai University of Engineering Science · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitochondrial dysfunction played a vital role in the pathogenesis of various diseases, including acute lung injury (ALI). However, few strategies targeting mitochondria were developed in treating ALI. Recently, we fabricated a porous Se@SiO

methodsThe protective effect of Se@SiO

resultsThis study demonstrated that Se@SiO

conclusionThis study brought new insights into mitochondria-targeting bioactive NPs, with application potential in curing ALI or other human mitochondria-related disorders.

Indexed as

Acute Lung InjuryAnimalsAntioxidantsCell LineCytoprotectionDisease Models, AnimalEpithelial CellsHumansLipopolysaccharidesLungMiceMitochondriaNanoparticlesOxidation-ReductionOxidative StressPorosityAntioxidantsLipopolysaccharidesSeleniumSilicon Dioxideacute lung injuryanti-inflammationanti-oxidative injurymitochondrial dysfunctionporous Se@SiO2 nanoparticles

Identifiers

PMID32280221
PMCPMC7127826
OpenAlexW3013298367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.